Back to Trades
Peetz Christopher
DirectorCIK 0001614740
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 11
- Buy transactions
- 0
- Sell transactions
- 15
- Companies
- 2
- Active
- 2025–2026
Peetz Christopher, Director, has filed 11 SEC reports (2025–2026), spread across 2 companies, totaling $24.6M in disclosed volume. Weighing $0 bought versus $15.4M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| Jul 17 | ARQT Arcutis Biotherapeutics, Inc. | Peetz Christopher | Director | Grant | $958.3K |
| Jul 17 | ARQT Arcutis Biotherapeutics, Inc. | Peetz Christopher | Director | Other | $0 |
| Jul 8 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher | Insider | Sell | $2.4M |
| Jun 2 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher | Insider | Sell | $2.9M |
| Mar 17 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher | Insider | Sell | $3.8M |
| Feb 3 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher | Insider | Sell | $940.9K |
| Jan 30 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher | Insider | Award | $6.8M |
| Jan 23 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher | Insider | Sell | $662.4K |
| Nov 20 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher | Insider | Exercise | $736.2K |
| Aug 12 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher | Insider | Sell | $2.5M |
| Aug 8 | MIRM Mirum Pharmaceuticals, Inc. | Peetz Christopher | Insider | Sell | $2.2M |
11 filings